Ablative therapy for esophageal dysplasia and early malignancy: focus on RFA

Biomed Res Int. 2014:2014:642063. doi: 10.1155/2014/642063. Epub 2014 Jul 21.

Abstract

Ablative therapies have been utilized with increasing frequency for the treatment of Barrett's esophagus with and without dysplasia. Multiple modalities are available for topical ablation of the esophagus, but radiofrequency ablation (RFA) remains the most commonly used. There have been significant advances in technique since the introduction of RFA. The aim of this paper is to review the indications, techniques, outcomes, and most common complications following esophageal ablation with RFA.

Publication types

  • Review

MeSH terms

  • Argon Plasma Coagulation*
  • Barrett Esophagus / epidemiology
  • Barrett Esophagus / pathology
  • Barrett Esophagus / therapy*
  • Cryotherapy*
  • Endoscopy
  • Esophageal Neoplasms / epidemiology
  • Esophageal Neoplasms / pathology
  • Esophageal Neoplasms / therapy*
  • Humans
  • Photochemotherapy*